Delivery Order SPE2DB22D2206-SPE2DB24FDW47
Award Date 10/25/23
Potential Completion Date 11/16/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,176.86 firm fixed-price delivery order is for the supply of EXJADE 500 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, with a firm fixed price and a ceiling value of $4,006.76. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,206.51 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of EXJADE 500 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This federal contract award is for the delivery of EXJADE 250 MG TABLET 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,034.60 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 13, 2023, with a completion date of August 3, 2023. The contract is a delivery order placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $16,027.08 and a period of performance through July 16, 2025. The contract is a firm fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier, to provide EXJADE 125 MG TABLET 30S for $6,761.12. This order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXJADE 250 MG TABLET 30S. The contract has a potential value of $3,418.22 and a completion date of January 25, 2024. The contract supports the provision of pharmaceuticals and medical supplies to military treatment programs and facilities. No set-aside designation was used for this award....
- This federal contract award is for the delivery of EXJADE 250 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The contract has a ceiling value of $3,418.22 and an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Cencora, Inc. organization, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,535.42 contract is for the delivery of Exjade 125 mg tablets and has an ultimate completion date of August 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,027.08 for Exjade 500 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract, which is not set-aside, represents a routine pharmaceutical supply requirement fulfilled by the prime contractor at its Conshohocken, Pennsylvania facility. The award is issued as a child contract under AmerisourceBergen's larger Indefinite...